---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-034176"
form_type: "8-K"
ticker: null
cik: "0000819050"
company_name: "Fresh Tracks Therapeutics, Inc."
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T03:04:16.295399+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CEO Sklawer departs; severance includes $441K lump sum, full equity vesting, $425/hr consulting

## Summary
- CEO Andrew Sklawer terminated without cause effective Oct 2, 2023; severance of $441k (12 months base) plus $44k retention bonus.
- Accrued PTO paid $165,375; health care premiums for 12 months with 35% gross-up if continued coverage not available.
- All unvested equity awards fully vested as of Separation Date; equity exercise extended to 3 years.
- Sklawer to provide consulting via Yonder Partners at $425 per hour; contract terminable by either party.
- CEO departure in connection with previously disclosed plan to liquidate and dissolve the company.

## SEC filing metadata
- accession: 0001628280-23-034176
- form_type: 8-K
- cik: 0000819050
- company_name: Fresh Tracks Therapeutics, Inc.
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/819050/000162828023034176/0001628280-23-034176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/819050/000162828023034176/frtx-20231003.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-034176
- JSON: https://secwatch.observer/filing/0001628280-23-034176.json
- Plain text: https://secwatch.observer/filing/0001628280-23-034176.txt

## Key facts
- Executive change
  Andrew D. Sklawer was terminated as President and Chief Executive Officer at Fresh Tracks Therapeutics, Inc..
  - Action: terminated
  - Role: President and Chief Executive Officer
  source text: the Company terminated Andrew D. Sklawer, the Company’s President and Chief Executive Officer, without cause, effective October 2, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/819050/000162828023034176/0001628280-23-034176-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.